Moderna Inc on late Thursday (March 17) sought emergency use authorisation with US health regulators for a second COVID-19 booster shot, as a surge in cases in some parts of the world fuels fears of another wave of the pandemic.

Moderna seeks FDA authorisation for second COVID-19 booster for all adults

Britain has secured 5 million doses of an experimental COVID-19 vaccine developed by Moderna Inc after it reported positive trial results, health minister Matt Hancock said on Monday (November 16), with the earliest doses expected for delivery in spring.

UK secures 5 million doses of Moderna COVID-19 vaccine

Moderna Inc said on Monday (November 16) its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations.

Moderna says coronavirus vaccine 94.5% effective

US biotech firm Moderna on Monday announced its experimental vaccine against Covid-19 was 94.5 percent effective, marking a second major breakthrough in the vaccine hunt.

WION Dispatch: Moderna says its COVID-19 vaccine is over 94% effective

mordera-vaccine

Mordera Vaccine, News on Mordera Vaccine, stories on Mordera Vaccine, articles on Mordera Vaccine, Mordera Vaccine stories at Wion, Mordera Vaccine news, Mordera Vaccine latest news

mordera vaccine

Moderna seeks FDA authorisation for second COVID-19 booster for all adults

UK secures 5 million doses of Moderna COVID-19 vaccine

Moderna says coronavirus vaccine 94.5% effective

WION Dispatch: Moderna says its COVID-19 vaccine is over 94% effective